These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20017449)

  • 1. Pulmonary arterial hypertension--contemporary management strategy.
    Jansa P; Ambroz D; Maresova J; Polacek P; Aschermann M; Linhart A
    Bratisl Lek Listy; 2009; 110(10):603-8. PubMed ID: 20017449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension and women.
    De Marco T
    Cardiol Rev; 2006; 14(6):312-8. PubMed ID: 17053380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment algorithm for pulmonary arterial hypertension].
    Hoeper MM
    Herz; 2005 Jun; 30(4):326-31. PubMed ID: 15965810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated treatment algorithm of pulmonary arterial hypertension.
    Galiè N; Corris PA; Frost A; Girgis RE; Granton J; Jing ZC; Klepetko W; McGoon MD; McLaughlin VV; Preston IR; Rubin LJ; Sandoval J; Seeger W; Keogh A
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D60-72. PubMed ID: 24355643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension: pathobiology, diagnosis and treatment.
    Golpon HA; Welte T; Hoeper MM
    Minerva Med; 2005 Aug; 96(4):303-14. PubMed ID: 16179896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary arterial hypertension, a rare entity].
    Morales-Blanhir JE; Carmona-Rubio AE; Rosas-Romero Mde J; Vergara de Márquez GS; Arbo-Oze-de-Morvil GA
    Rev Invest Clin; 2014; 66(1):65-78. PubMed ID: 24762728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary arterial hypertension: modern diagnostics and therapy--Part 1].
    Betkier-Lipińska K; Ryczek R; Kwasiborski P; Cwetsch A
    Pol Merkur Lekarski; 2013 Jun; 34(204):355-9. PubMed ID: 23882936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapies for pulmonary arterial hypertension.
    Takaoka S; Faul JL; Doyle R
    Semin Cardiothorac Vasc Anesth; 2007 Jun; 11(2):137-48. PubMed ID: 17536117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways and Drugs in Pulmonary Arterial Hypertension - Focus on the Role of Endothelin Receptor Antagonists.
    Madonna R; Cocco N; De Caterina R
    Cardiovasc Drugs Ther; 2015; 29(5):469-79. PubMed ID: 26145170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations for optimal management of patients with pulmonary arterial hypertension: a multi-stakeholder roundtable discussion.
    Studer SM; Kingman M; Calo L; Cannon HE; Dunn JD; James T; Lewis SJ; Gilkin RJ; Pruett JA
    Am J Manag Care; 2017 May; 23(6 Suppl):S95-S104. PubMed ID: 28715904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-related pulmonary arterial hypertension: clinical presentation and management.
    Sitbon O
    AIDS; 2008 Sep; 22 Suppl 3():S55-62. PubMed ID: 18845923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary arterial hypertension in childhood].
    Douwes JM; van Loon RL; Roothooft MT; Berger RM
    Ned Tijdschr Geneeskd; 2011; 155(49):A3901. PubMed ID: 22166180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dana Point: what is new in the treatment of pulmonary hypertension?].
    Hoeper MM; Ghofrani HA; Grimminger F; Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S191-5. PubMed ID: 18814094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension.
    Theo Schermuly R; Ardeschir Ghofrani H; Weissmann N
    Curr Top Dev Biol; 2005; 67():251-84. PubMed ID: 15949537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach.
    Cicalini S; Almodovar S; Grilli E; Flores S
    Clin Microbiol Infect; 2011 Jan; 17(1):25-33. PubMed ID: 20545962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.